Kelman-Lazarov Inc’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-119
Closed -$88K 127
2017
Q2
$88K Buy
+119
New +$88K 0.05% 116
2017
Q1
Sell
-11
Closed -$8.13K 269
2016
Q4
$8.13K Sell
11
-41
-79% -$30.3K ﹤0.01% 263
2016
Q3
$54.9K Buy
52
+9
+21% +$9.51K 0.03% 171
2016
Q2
$33.1K Hold
43
0.02% 195
2016
Q1
$34K Buy
+43
New +$34K 0.02% 210